Research Topics
| Fujie ZhangSummaryAffiliation: Chinese Center for Disease Control and Prevention Country: China Publications
| Collaborators
|
Detail Information
Publications
Therapeutic drug monitoring in highly active antiretroviral therapyXia Liu
National Center for AIDS STD Control and Prevention, Chinese Center for Disease Control and Prevention, 27 Nan Wei Road, Beijing 100050, China
Expert Opin Drug Saf 9:743-58. 2010..Therapeutic drug monitoring (TDM) has been utilised to improve treatment outcomes of ART...
Overview of HIV drug resistance and its implications for ChinaFu-jie Zhang
Division of Treatment and Care, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
Chin Med J (Engl) 119:1999-2004. 2006- Chinese pediatric highly active antiretroviral therapy observational cohort: a 1-year analysis of clinical, immunologic, and virologic outcomesFujie Zhang
Chinese Center for Disease Control and Prevention, National Center for AIDS, Division of Treatment and Care, Beijing, China
J Acquir Immune Defic Syndr 46:594-8. 2007..Few data are available on the outcomes of pediatric antiretroviral therapy (ART) in the developing world... - The Chinese free antiretroviral treatment program: challenges and responsesFujie Zhang
National Center for AIDS STD Control and Prevention Chinese Center for Disease Control and Prevention, Beijing, China
AIDS 21:S143-8. 2007..The Free ART Program has made considerable progress in providing the necessary care and treatment for HIV-infected people in China and has strong government support for continued improvement and expansion... 
The effect of highly active antiretroviral therapy on mortality among HIV-infected former plasma donors in ChinaFujie Zhang
National Center for AIDS STD Control and Prevention, Chinese Center for Disease Control and Prevention, Ditan Hospital, Beijing, China
Clin Infect Dis 47:825-33. 2008..Highly active antiretroviral therapy (HAART) was provided for former plasma donors beginning in 2002. The effect of HAART on mortality in this cohort has not been described...- Five-year outcomes of the China National Free Antiretroviral Treatment ProgramFujie Zhang
National Center for AIDS STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
Ann Intern Med 151:241-51, W-52. 2009..China's National Free Antiretroviral Treatment Program began in 2002 and, by August 2008, included more than 52 000 patients... - Recent key advances in human immunodeficiency virus medicine and implications for ChinaKai Sun
School of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA
AIDS Res Ther 7:12. 2010..Lastly, we review important achievements of and future challenges facing China as she steps into her eighth year of the National Free Antiretroviral Treatment Program... - Association between missed early visits and mortality among patients of china national free antiretroviral treatment cohortYao Zhang
Division of Treatment and Care, National Center for AIDS STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, PR China
J Acquir Immune Defic Syndr 60:59-67. 2012..However, few studies have evaluated indicators for patient access to medical care and their association with mortality... - Gender difference in 2-year mortality and immunological response to ART in an HIV-infected Chinese population, 2006-2008Zhihui Dou
Chinese Center for Disease Control and Prevention, Beijing, China
PLoS ONE 6:e22707. 2011..Gender differences, however, in mortality and immunological response to ART in this cohort have never been described... - Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort studyFujie Zhang
Division of Treatment and Care, National Centre for AIDS STD Control and Prevention, Chinese Centre for Disease Control and Prevention, Beijing, China
Lancet Infect Dis 11:516-24. 2011..Overall HIV mortality rates in China have not been reported. In this analysis we assess overall mortality in treatment-eligible adults with HIV and attempt to identify risk factors for HIV-related mortality... - Predictors of virologic failure in HIV-1-infected adults receiving first-line antiretroviral therapy in 8 provinces in ChinaYe Ma
National Center for AIDS STD Control and Prevention, Chinese Center for Disease Control and Prevention, US Embassy, Beijing, China
Clin Infect Dis 50:264-71. 2010..Despite poor primary health care systems, free antiretroviral therapy (ART) has been available in China for >5 years. Virologic outcomes in Chinese patients receiving ART have not been described on a national level... - Changing baseline characteristics among patients in the China National Free Antiretroviral Treatment Program, 2002-09Zhihui Dou
Chinese Center for Disease Control and Prevention, Beijing, People s Republic of China
Int J Epidemiol 39:ii56-64. 2010..To improve HIV treatment in China by determining changes over time of patient characteristics (geographic, clinical and route of HIV infection) among patients enrolled in the China National Free Antiretroviral Treatment Program... - Monitoring HIV drug resistance using early warning indicators in China: results from a pilot survey conducted in 2008Ye Ma
Division of Treatment and Care, National Center for AIDS STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
Clin Infect Dis 54:S300-2. 2012..HIV drug resistance early warning indicator monitoring provides a valuable assessment of ART service delivery, and its application will be scaled up throughout China... - The diagnosis and treatment of HIV-infected children in China: challenges and opportunitiesFujie Zhang
National Center for AIDS STD Control and Prevention, Chinese Center for Disease Control, Beijing, People s Republic of China
J Acquir Immune Defic Syndr 44:429-34. 2007..This national survey describes the demographic characteristics and the associated diagnostic and antiretroviral treatment (ART) efforts directed toward surviving HIV-infected children... - Progress of the National Pediatric Free Antiretroviral Therapy program in ChinaYan Zhao
National Center for AIDS STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, Xuan Wu District, China
AIDS Care 22:1182-8. 2010..Secondly, much of the pediatric ARV drug supply depends on donation. An effort needs to be made by the Chinese Government to establish China's own drug procurement and supply system... - Mortality and treatment outcomes of China's National Pediatric antiretroviral therapy programYan Zhao
National Center for AIDS STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, PR China
Clin Infect Dis 56:735-44. 2013..The aim of this study was to describe 3-year mortality rates, associated risk factors, and long-term clinical outcomes of children enrolled in China's national free pediatric antiretroviral therapy (ART) program... - HIV-infected former plasma donors in rural Central China: from infection to survival outcomes, 1985-2008Zhihui Dou
Chinese Center for Disease Control and Prevention, Beijing, China
PLoS ONE 5:e13737. 2010..The objectives of this study are to estimate the timing and geographic spread of HIV infection in this cohort and to demonstrate the impact of antiretroviral therapy on survival outcomes... - CD14(high)CD16(+) rather than CD14(low)CD16(+) monocytes correlate with disease progression in chronic HIV-infected patientsJunyan Han
Institute of Infectious Diseases, Capital Medical University, Beijing, China
J Acquir Immune Defic Syndr 52:553-9. 2009..Because CD14(+)CD16(+) monocytes are a heterogeneous population and consist of CD14(high)CD16(+) and CD14(low)CD16(+) subsets, we evaluated the effects of HIV infection on distinct subsets of CD16(+) monocytes... - Hepatitis B and hepatitis C seroprevalence in children receiving antiretroviral therapy for human immunodeficiency virus-1 infection in China, 2005-2009Shuntai Zhou
Division of Treatment and Care, National Center for AIDS STI Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
J Acquir Immune Defic Syndr 54:191-6. 2010..In this study, we evaluated the seroprevalence of HBV and HCV in children receiving ART and associated factors... - Quantitatively monitoring AIDS policy implementation in ChinaYufen Liu
Chinese Center for Disease Control and Prevention, Beijing, China
Int J Epidemiol 39:ii90-6. 2010..We tested a hypothesis that incrementally setting realistic quantitative targets for key indicators and monitoring performance would facilitate AIDS policy implementation in China... - Drug resistance profiles among HIV-1-infected children experiencing delayed switch and 12-month efficacy after using second-line antiretroviral therapy: an observational cohort study in rural ChinaYan Zhao
Division of Treatment and Care, National Center for AIDS STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
J Acquir Immune Defic Syndr 58:47-53. 2011.... - Methadone maintenance treatment and mortality in HIV-positive people who inject opioids in ChinaYan Zhao
National Center for AIDS STD Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Road, Changping District, Beijing, 102206, China
Bull World Health Organ 91:93-101. 2013..To examine the effect of methadone maintenance treatment (MMT) on mortality in people injecting opioids who receive antiretroviral therapy (ART) for the treatment of human immunodeficiency virus (HIV) infection in China... - Estimating the number of people living with HIV/AIDS in China: 2003-09Ning Wang
Chinese Center for Disease Control and Prevention, Beijing, China
Int J Epidemiol 39:ii21-8. 2010..Subsequent national estimation exercises were carried out in 2005, 2007 and 2009. We describe these estimation processes and present the results of China's HIV/AIDS estimation exercises from 2003 to 2009... - [A clinical trial using zidovudine and lamivudine plus indinavir triple therapy in Chinese individuals with human immunodeficiency virus infection]Yunzhen Cao
Laboratory of Clinical Virology, AIDS Prevention and Control Center, Ministry of Health, Beijing 100050, China
Zhonghua Nei Ke Za Zhi 41:109-13. 2002..CONCLUSION: It is effective for the virus with different genotype. The results will form a scientific foundation for the development of therapeutic strategies for HIV infection in China...